Drexell Boggs, MD
Radiation Oncology · Birmingham, ALNPI 1003131558
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (53.7%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. 7 manufacturers reported payments, led by Siemens Medical Solutions USA, Inc. at 54.9% of the total. Among radiation oncology clinicians in AL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 46 payments — averaging $762.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Siemens Medical Solutions USA, Inc.$19K
- Varian Medical Systems, Inc.$14K
- Novocure Inc.$2K
- Progenics Pharmaceuticals, Inc.$31
- Amgen$19
- Ipsen Biopharmaceuticals, Inc$18
- plus $15 from 1 others
Across 8 payments — averaging $15,728 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Siemens Medical Solutions USA, Inc.$63K
- Varian Medical Systems, Inc.$40K
- Novocure Inc.$23K
What the payments were for
- Consulting fees$4,00011%
- Speaking & faculty fees$18,85054%
- Travel & lodging$10,84731%
- Food & beverage$1,3914%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Siemens Medical Solutions USA, Inc. | 25 | $19,268 |
| Varian Medical Systems, Inc. | 15 | $13,711 |
| Novocure Inc. | 2 | $2,026 |
| Progenics Pharmaceuticals, Inc. | 1 | $31 |
| Amgen | 1 | $19 |
| Ipsen Biopharmaceuticals, Inc | 1 | $18 |
| AstraZeneca | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Edge$13,062
- Varian Ethos Treatment Planning$7,098
- TrueBeam$2,521
- Eclipse Treatment Planning System for External Beam Radiation Therapy$2,109
- Oncology$2,000
- Halcyon$896
- Clinac iX$460
How this compares
$35,089 in reported general payments places this provider in the 95th percentile of 87 radiation oncology providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Triamcinolone Acetonide | 53 | $321 |
| Tamsulosin Hcl | 12 | $84 |
Paid to pharmacies, not to this prescriber.
Other radiation oncology in Birmingham
- Christopher WilleyBirmingham$13K
- Adam KoleBirmingham$11K
- Andrew McDonaldBirmingham$8K
- William EnnisBirmingham$6K
- John StahlBirmingham$3K
- Omer BurnettBirmingham$2K
- Samuel MarcromBirmingham$2K
- Rojymon JacobBirmingham$1K
- Mehran YusufBirmingham$1K
- Ruby MeredithBirmingham$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.